Erasca Raises $64M For Oncology Drug Development Using AI
socalTECH
MARCH 5, 2019
San Diego-based Erasca , a company which is using artificial intelligence to drive the discovery and development of new oncology drugs to help cure cancer, has raised $64M in a Series A funding, the company said this morning. According to the company, the new funding will to towards.
Let's personalize your content